Soleno Therapeutics 주식 (NASDAQ: SLNO)

Soleno Therapeutics (NASDAQ:SLNO) 주식

SOLENO THERAPEUTICS INC

Soleno Therapeutics

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Southwest Gas Holdings Inc.

Biotech

Equities

Fintech news covering the emerging Financial Technology services sector

Fintech

Large Cap

Market Summary

Mid Cap

Health Care

Small Cap

Tech

$BTC

AVGO

CVNA

MSTR

NVDA

SLNO

TSLA

VERA

엔비디아(NASDAQ:NVDA)는 지난 1년간 수익률 순위에서 나스닥 100 지수 1위를 차지하며 눈에 띄는 기술 주식이었다.
이 칩 제조업의 거인은 인공지능(AI) 개발을 위한 칩에 대한 급증하는 수요로, 지난 2023년 5월 말 이후 무려 186%나 급등했다.

엔비디아는 1년 전 대비 186% 상승했지만, 다음의 7개 주식은 이보다 두 배 이상의 수익 기록

Soleno Therapeutics Inc

WIIM

International Paper shares are trading lower on continued weakness after the company last week reported worse-than-expected Q1 adjusted EPS results.

SBUX

Starbucks shares are trading lower on continued weakness after the company last week reported worse-than-expected Q2 financial results.

The Supreme Court of British Columbia has granted an order approving the full separation of Lions Gate Entertainment Corp.'s Studio and STARZ businesses into two independent, publicly-traded companies. The separation is anticipated to take place tomorrow, Tuesday, May 6th. Lionsgate is expected to begin trading on the New York Stock Exchange under the ticker symbol LION on Wednesday, May 7th.

News

Lions Gate Entertainment Corporation Class A Voting Shares

LGF/A

Lions Gate Entertainment Corporation Class B Non-Voting Shares

LGF/B

LION

Lionsgate Secures Court Approval For Studio And STARZ Businesses Split, Lionsgate Is Expected To Begin Trading On The NYSE Under The Ticker Symbol "LION" On May 7

The U.S. Treasury Department has sharply increased its borrowing estimate for the current quarter, projecting $514 billion in net marketable debt from April through June. That marks a stunning 317% jump from its earlier forecast of $123 billion, made just two months ago.
<h2 class="wp-block-heading">What Changed?</h2>
The big shift is largely due to the government starting the quarter with far less cash on hand than expected. <a href="https://www.bloomberg.com/news/articles/2025-04-28/us-boosts-net-borrowing-estimate-to-514-billion-this-quarter">Bloomberg</a> reported in February that the Treasury expected to have $850 billion in its coffers by the end of March. Instead, the balance was just $406 billion.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
&#8220;Excluding the lower than assumed beginning-of-quarter cash balance, the current quarter borrowing estimate is $53 billion lower than announced in February,&#8221; Treasury <a href="https://home.treasury.gov/news/press-releases/sb0115">said</a> on Monday.
Bloomberg reported that lower balance is mostly the result of Congress still not raising the federal debt ceiling, which limits the government's ability to issue new debt. The Treasury is still assuming that the debt limit will be resolved and says it expects to have $850 billion in cash by the end of June. But if that doesn&#8217;t happen, borrowing would likely come in $53 billion lower than planned.
<h2 class="wp-block-heading">Looking Ahead</h2>
For the July through September quarter, the Treasury expects to borrow $554 billion, again assuming the cash balance reaches $850 billion by the end of the period.
The department also revised its look back at the first quarter of 2025. It had expected to borrow $815 billion but ended up needing just $369 billion, mainly due to ending that quarter with $444 billion less in cash than assumed.
Trending: <a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a>
According to Bloomberg, Wall Street had been bracing for a sharp increase in borrowing needs. JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) had forecast $255 billion in borrowing for the current quarter, based on a much lower cash balance projection. Meanwhile, Bloomberg also cites Lou Crandall, senior economist at Wrightson ICAP, who warned even before the announcement that the Treasury might raise its estimate if it continued assuming an &#8220;unrealistic&#8221; $850 billion end-of-quarter balance.
Crandall also said that President Donald Trump's recent <a href="https://www.benzinga.com/markets/25/04/44831287/trump-administration-imposes-up-to-245-tariff-on-chinese-imports-amid-intensifying-trade-battle">hikes in import duties</a> could be influencing Treasury's cash planning, as higher customs revenues flow in.
<h2 class="wp-block-heading">Public Reaction</h2>
The news of the Treasury's updated borrowing plan has stirred up a wave of reactions <a href="https://x.com/unusual_whales/status/1917161185482621188">online</a>. Some pointed out the irony of increased debt under a political movement that once promised fiscal discipline. Others questioned how the government could miscalculate its cash position so drastically in just a few months.
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a>
Concerns also surfaced about how the surge in borrowing might affect everyday Americans, with several users warning that higher debt could result in <a href="https://www.benzinga.com/news/econ-s/25/04/45022780/high-mortgage-rates-economic-uncertainty-rain-on-spring-home-buying-season">rising mortgage rates</a>, credit card interest, and other borrowing costs.
There was also criticism of <a href="https://www.benzinga.com/news/25/04/44873656/josh-hawley-proposes-historic-tax-cuts-for-americans-earning-below-80k-annually-republicans-should-f">proposed tax cuts</a> and <a href="https://www.benzinga.com/news/25/02/43980072/theres-no-reason-to-spend-1-trillion-on-the-military-trumps-statement-sends-us-defense-stocks-spiraling-whil">military budget increases</a>, with some highlighting the Pentagon's repeated failures to pass audits. A few questioned why the government needs to borrow its own currency in the first place, while others expressed frustration over what they see as a lack of accountability and fiscal responsibility.
Overall, the responses reflect widespread unease about the economic implications of the Treasury's revised estimates and what they signal about the state of federal finances.
Read Next:
<ul>
<li>Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
Image: Shutterstock

US Treasury Ramps Up Borrowing Needs To $514 Billion, Marking A Surprising 320% Jump From Its Previous Forecast

Grant Cardone has built a large real estate portfolio and has helped others do the same. He often mentions that success is your duty while sharing the importance of multiplying your income so you can escape the middle class.
However, Cardone's definition of success goes far beyond stacking dollar bills. He touches on this in his book "Be Obsessed Or Be Average." Cardone explains that some people are financially successful but have bad relationships and feel unfulfilled.
"Success is about being great at many things," Cardone explained.&nbsp;
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Thriving In Multiple Areas</h2>
Cardone strives to grow his finances, but he also prioritizes other things, such as his family and fitness. He attributes this to being obsessed. Cardone has a desire to discover what he is capable of and goes all-in on the things he cares about.
You can be good at multiple things and be obsessed in those areas, but you need clarity first. Cardone encourages people to write a list of their biggest goals. If it comes to mind, write it down, and don't minimize it.&nbsp;
Writing big goals and striving to be successful in multiple areas will expand your thinking. Life also gets more exciting when you pursue ambitious goals instead of small goals that barely move you forward. Know what areas you want to be good at and then create plans for each one.
Trending: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
<h2 class="wp-block-heading">Defining Success</h2>
We all have different definitions of success. Some people want to be home as much as possible, while others view success as starting multiple businesses that generate sizable profits.
Cardone gives a rough blueprint. Success is about being great at multiple things, but you have to decide which skills and hobbies to pursue. However, you don't have to initially like the work in the beginning.&nbsp;
Interestingly, Cardone didn't always like selling, but he knew it was an important skill. As he got better at it, he came to love selling and now coaches many business owners on how to close more deals. Your definition of success and the things you enjoy will change as you go.&nbsp;
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
<h2 class="wp-block-heading">Money Is Still Important</h2>
Although Cardone mentioned that some rich people lose out on other areas of their lives, he isn't an advocate of having a work-life balance. Some people may hear stories like these and state that money isn't everything.
While money isn't absolutely everything, having more money gives you more choices. Cardone frequently preaches this point since he knows what it's like to penny-pinch in the middle class.
Cardone saw his mother hunt for coupons and discounts after his father passed away. He saw how dangerous it was to operate paycheck to paycheck and hoping that his father's best egg would be enough.
He doesn't put money on the altar. Cardone goes all-in on various parts of his life, but he's not the type to slow down when it comes to making money and discovering new business opportunities. You don't have to choose between making a lot of money and being present in your family. Obsessed people can figure out how to do both effectively.&nbsp;
Read Next:
<ul>
<li>Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Personal Finance

Grant Cardone Explains Why Some Rich People Still Feel Unfulfilled: 'Success Is About Being Great At Many Things'

Dave Ramsey has been hosting "The Ramsey Show" for decades. He has spoken with many callers and has gone through quite a transformation since he started selling books from the back of his truck.
However, the more things change, the more they stay the same. Ramsey found himself in a <a href="https://www.youtube.com/watch?v=uu3BNkFoa2E">deja vu moment</a> when a caller asked him about building wealth in the current economy.&nbsp;
The caller has been listening to Ramsey since he was a child, and he is now 26 years old. He jumped on the show to ask Ramsey about building wealth in the current economy. It can seem bleak with tariffs capturing all of the headlines, but Ramsey encouraged the caller and other listeners to remain calm.
"This is not the first time the stock market has gone down," Ramsey said during the call.&nbsp;
Ramsey proceeded to offer a lesson in crafting an investor's mindset and how he views the current economy.
<h2 class="wp-block-heading">When In Doubt, Zoom Out</h2>
Ramsey has been a financial guru for decades, so he has heard from callers over the years during stock market panics. For instance, he explained that people thought the world was going to end during the pandemic and that the U.S. economy would never recover.
While headlines seemed to agree with that consensus, Ramsey held his equities and benefited from the sharp recovery. Right now, a similar story is unfolding, where large publications are posting negative headlines about the stock market.
"The news is full of drama queens," Ramsey said while encouraging the caller to tune out the noise.&nbsp;
If you zoom out the S&amp;P 500 over the past five years, you will see some solid returns. Those returns get even better when you look over the past 10-20 years. However, you don't even have to look that far. Ramsey mentioned that the S&amp;P 500 gained more than 50% from the start of 2023 to the end of 2024.
<h2 class="wp-block-heading">Regularly Invest</h2>
Ramsey is an advocate of regularly buying reliable companies. He mentioned at the end of the call that he invests when the stock market is going up and also buys shares when the stock market is going down. He's not focused on the short-term noise and focuses on a stock's long-term potential instead.
He also said that he's looking for extra money to buy some extra shares during this period of economic uncertainty. Ramsey explained that Wall Street loathes uncertainty, and that's part of the reason why the market has delivered some big red days in recent weeks.&nbsp;
Investors who can ride the uncertainty may have the potential to generate strong returns. It's similar to Trump's tariffs during his first term. Investors panicked in 2018, and many of them sold their shares. Then, the stock market came roaring back in 2019, much to the delight of patient investors.
<h2 class="wp-block-heading">Younger Investors Typically Take More Risk</h2>
The caller mentioned that he is 26 years old, and that's normally an age where investors can take more risks. While we don't know enough about the caller's financial situation, it may be feasible for him to buy and hold stocks for many years, if not decades.
A lengthier time horizon gives you more time for assets to recover before you consider selling them. While it's optimal to buy and hold stocks forever, the caller should consider if he may have to sell shares within a few years to buy a house. However, the caller may be a few years away from that point.&nbsp;
You can also make low-risk investments, but the problem with these assets is that they produce low returns. CDs and high-yield savings accounts keep your money safe from stock market crashes, but these assets have woefully underperformed the S&amp;P 500 in the long run. The caller should assess how much risk he is willing to take and not let short-term noise distract him from his long-term financial goals.
Image: Shutterstock

Dave Ramsey Explains How To Build Wealth In The Current Economy: 'This Is Not The First Time The Stock Market Has Gone Down'

True Anomaly, a Colorado-based space defense startup, has secured $260 million in Series C funding to accelerate the development of its Jackal <a href="https://www.benzinga.com/partner/news/25/04/45097684/from-powering-spacecraft-to-showing-off-its-manufacturing-might-ascent-solar-is-making-its-name-in-s">spacecraft</a> and Mosaic software platform.
The company announced in a<a href="https://www.trueanomaly.space/newsroom/announcing-our-260m-fundraise"> statement</a> that the <a href="https://www.benzinga.com/25/04/44580172/openai-finalizes-historic-40-billion-funding-round-valuing-company-at-300-billion-with-backing-from-softbank-and-microsoft">funding round</a> was led by Accel, with participation from Meritech Capital, Eclipse, Riot Ventures, Menlo Ventures, ACME Capital, Narya, 645 Ventures, Space VC, and Champion Hill Ventures.
<h2 class="wp-block-heading">True Anomaly is Building Tactical Tools for the Golden Dome Era</h2>
The startup, founded in 2022, is developing both hardware and software to automate satellite surveillance and enable tactical dominance in orbit, <a href="https://thedebrief.org/true-anomaly-is-creating-autonomous-orbital-pursuit-vehicles-and-space-security-tech-for-the-u-s-space-force/">The Debrief</a> writes.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
At the center of True Anomaly's platform is Jackal, a spacecraft engineered for close proximity operations. Designed with optical and radar sensors, Jackal can perform autonomous maneuvers, capture intelligence-grade imagery, and simulate defensive or offensive orbital tactics. According to the<a href="https://www.trueanomaly.space/jackal"> company</a>, the system is built for flexibility across multiple orbits and aims to meet the U.S. Space Force's increasing demand for responsive space capabilities.
Jackal's next mission is already locked in. The company <a href="https://www.trueanomaly.space/newsroom/true-anomaly-selected-for-30m-space-systems-command-contract-in-support-of-victus-haze-tactically-responsive-space-mission">announced</a> last year that it has secured a $30 million contract with the U.S. Space Force under its Tactically Responsive Space program, a major step that <a href="https://www.bloomberg.com/news/articles/2025-04-30/space-startup-looking-to-trump-s-golden-dome-raises-260-million">Bloomberg</a> says it aligns True Anomaly with future implementations of Trump's proposed "Golden Dome," a space-based missile and threat defense initiative modeled after Israel's Iron Dome. Firefly Aerospace will launch the spacecraft, making this one of the first commercial-public hybrid missions designed specifically for live military deployment, True Anomaly said.
Mosaic, the software platform powering these systems, is equally critical since it enables autonomous decision-making, live command-chain adjustments, and real-time satellite tasking, the company<a href="https://www.trueanomaly.space/mosaic"> says</a>. Where Jackal provides muscle, Mosaic delivers the brain, giving defense teams a digital layer of clarity in an environment where seconds matter.
Trending: Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.
<h2 class="wp-block-heading">Scaling Manufacturing, Workforce, And Influence</h2>
To meet growing production demands, True Anomaly<a href="https://www.trueanomaly.space/newsroom/true-anomaly-announces-significant-expansion-into-california-with-long-beach-campus"> announced</a> in February that&nbsp; it is doubling down on infrastructure. The company has broken ground on a 90,000-square-foot manufacturing facility in Long Beach, California, near Space Systems Command in El Segundo. This expansion positions the startup closer to key military clients and enhances its ability to deliver end-to-end solutions faster than traditional defense contractors.
Workforce growth is also underway. The team, which stood at 170 in early 2025, is expected to scale past 250 employees by next year. According to a <a href="https://www.builtinla.com/job/future-engineering-opportunities/4300788">job listing</a>, new hires are needed to work on propulsion systems, satellite autonomy, and ground-to-space integration.
Even Rogers, CEO of True Anomaly, framed the company's momentum to Bloomberg: &#8220;Our goal is to be a space superiority prime for the United States and its allies.&#8221;
True Anomaly's timing aligns with a global military focus that is rapidly shifting upward. With the Department of Defense signaling its intent to build a multi-layered orbital defense network, companies that can combine rapid production with live battlefield integration are getting first calls, <a href="https://insidedefense.com/share/223755">Inside Defense</a> writes.
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a>
The concept behind Golden Dome was described by Union of Concerned Scientists research director Laura Grego as technically unrealistic and financially daunting, <a href="https://www.reuters.com/business/aerospace-defense/musks-spacex-is-frontrunner-build-trumps-golden-dome-missile-shield-2025-04-17/">Reuters</a> reports, but is now reemerging in policy circles as a serious strategic objective. According to Bloomberg, True Anomaly has already responded to a request for information from the Missile Defense Agency, suggesting that its technologies are on the radar of the highest levels of government planning.
<h2 class="wp-block-heading">Future Outlook</h2>
The involvement of firms like Accel and Meritech shows growing confidence that venture-backed companies can play a central role in shaping the next era of defense technology alongside the legacy giants.
As the line between space tech and defense infrastructure continues to dissolve, True Anomaly is aiming for the center of the action, with $260 million in fuel and a mission that aligns with the new definition of national security.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Trump's Golden Dome Gets $260M Boost From Accel, Meritech, And Riot Ventures As True Anomaly Expands Military Space Tech

Grant Cardone isn't afraid of speaking harsh truths that can make people discover where they can improve. His book, "Be Obsessed Or Be Average," is filled with brutal truths, and he dropped a big one in chapter two.
"If you are living below your potential, it is only your fault."
This statement may be a hard pill to swallow for some people. It's easier and more comfortable to blame circumstances like your environment or upbringing. However, putting the entire blame on yourself suddenly puts you in control. This mentality can push you toward more ambitious goals for your career and finances.
Don't Miss:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Get Uncomfortable</h2>
Tapping into your potential requires getting out of your comfort zone. Cardone says he's at his weakest when he settles into his comfort zone, but he's at his best when he is pushing boundaries.
Each person has a different path outside of their comfort zone. It may involve taking more action, doing something new, or moving. Cardone says that moving to a new town or city can force you to meet new people and dial in on your goals.
You will have to get uncomfortable often to tap into your potential. If you are not willing to change, your results will not change.
Trending: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
<h2 class="wp-block-heading">Set Big Goals</h2>
Our goals influence how much we work and what we achieve in our lives. Whether you want to advance in your career or build a larger portfolio, setting big goals can help you unlock more of your potential.
Cardone says it's good to set big goals, but you should never reduce them. Instead of reducing targets, Cardone believes that you should take more action to move closer to your high benchmark.&nbsp;
Big goals also make it easier to work harder and continue to push when others want to call it a day. Ambitious goals set the stage for incredible rewards, but you can only get the best rewards by working harder than your peers.&nbsp;
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
<h2 class="wp-block-heading">Changing The Script</h2>
You are responsible for where you are right now and how you choose to move forward. Being obsessed and fully embracing your goals can help you on the path to unlocking your potential.
However, it's important to avoid blaming people or circumstances when things don't go your way. High performers also shy away from any excuses and focus on how they can improve.
It's never too late to tap into your potential. Cardone was a drug addict in his early 20s, but he turned it around by taking responsibility for his life and committing to big goals.&nbsp;
Change isn't easy, but staying where you are may be more difficult in the long run.&nbsp;
Read Next:
<ul>
<li>Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Grant Cardone Offers A Harsh Truth For Underperformers: 'If You Are Living Below Your Potential, It Is Only Your Fault'

Ross Gerber, CEO of Gerber Kawasaki Wealth &amp; Investment Management, has taken to social media to unload on the Trump administration&#8217;s trade policy and what he says is a lack of transparency from major companies like Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
&#8220;All companies should display the tariff cost as it is a tax on consumers,&#8221; Gerber <a href="https://x.com/GerberKawasaki/status/1917228510596177984">posted</a> last week on X, responding in part to recent comments by President Donald Trump suggesting that <a href="https://www.benzinga.com/markets/25/04/44944580/trump-says-tariffs-could-replace-income-tax-experts-warn-the-math-doesnt-work">tariffs could replace income taxes</a> for many Americans. &#8220;While they push this no income tax fantasy, the reality is this is the biggest tax HIKE on the average American family in modern history. Amazon should be transparent.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">All companies should display the tariff cost as it is a tax on consumers. While they push this no income tax fantasy, the reality is this is the biggest tax HIKE on the average American family in modern history. Amazon should be transparent. <a href="https://twitter.com/search?q=%24AMZN&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$AMZN</a>
&mdash; Ross Gerber (@GerberKawasaki) <a href="https://twitter.com/GerberKawasaki/status/1917228510596177984?ref_src=twsrc%5Etfw">April 29, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Amazon Denies Tariff Transparency Plan</h2>
The post came on the same day a Punchbowl News <a href="https://punchbowl.news/article/tech/amazon-display-tariff-costs/">report</a> claimed Amazon was planning to show import charges on its main site. The White House jumped in quickly, with press secretary Karoline Leavitt <a href="https://www.benzinga.com/trading-ideas/movers/25/04/45067585/amazon-stock-tumbles-as-white-house-calls-tariff-visibility-plans-a-hostile-act">calling the alleged move</a> &#8220;a hostile and political act by Amazon.&#8221;&nbsp;
On its <a href="https://www.aboutamazon.com/news/retail/amazon-response-to-white-house-tariffs">website</a>, Amazon responded by saying no such plan existed for its main platform: &#8220;The team that runs our ultra low cost Amazon Haul store considered the idea of listing import charges on certain products. This was never approved and is not going to happen.&#8221; Haul is Amazon&#8217;s budget-focused unit that competes with sites like Temu and Shein.
President Trump even <a href="https://www.benzinga.com/markets/equities/25/04/45090925/trumps-call-to-jeff-bezos-over-amazons-tariff-display-plans-draws-criticism-from-peter-schiff-this-is-the-type-of-stuff-you-might-expect-to-see-in-china">called Amazon founder</a> and executive chairman Jeff Bezos to complain about the situation, later telling reporters, &#8220;He solved the problem very quickly. He did the right thing.&#8221;
Trending: Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.
<h2 class="wp-block-heading">Backlash and Support Online</h2>
Gerber's post sparked widespread debate online. One X user <a href="https://x.com/DaddyLoser/status/1917232950233506153">replied</a>, "This is awesome – now I know it's not made in the U.S. and I can shop elsewhere." Others called for even more accountability: "Be transparent and hold Republicans accountable for this mess," one person <a href="https://x.com/MissJilianne/status/1917231846859149439">posted</a>.
Several commenters compared the idea to how shipping companies add a fuel surcharge, calling tariff breakdowns on consumer products a &#8220;no-brainer.&#8221;
<h2 class="wp-block-heading">Microsoft and the Bigger Picture</h2>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Says a man who never built a company… <a href="https://t.co/HLgKUnRpvM">https://t.co/HLgKUnRpvM</a>
&mdash; Ross Gerber (@GerberKawasaki) <a href="https://twitter.com/GerberKawasaki/status/1917954931459526879?ref_src=twsrc%5Etfw">May 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a>
Gerber doubled down after U.S. Treasury Secretary Scott Bessent told <a href="https://finance.yahoo.com/news/treasury-secretary-scott-bessent-to-americas-biggest-ceos-stop-worrying-121627070.html">Yahoo Finance</a> that CEOs stop worrying about tariffs and get back to business.
&#8220;Says a man who never built a company&#8230;&#8221; Gerber <a href="https://x.com/GerberKawasaki/status/1917954931459526879">replied</a>.
In another <a href="https://x.com/GerberKawasaki/status/1917954441908727889">post</a>, he warned that Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) was hiking Xbox prices by up to $100 because of tariffs. &#8220;When tariffs hit the rest of society&#8230; this isn't going to go well,&#8221; he said.
With all sides weighing in, Gerber&#8217;s message has struck a nerve: if tariffs are here to stay, Americans deserve to see exactly how much they're paying and for what.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
Image: Shutterstock

AMZN

MSFT

Ross Gerber Blasts Amazon, Trump. Says The No Income Tax Is A Fantasy, 'Tariffs The Biggest Tax Hike On American Family In Modern History'

Manitowoc Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTW#NYSE">MTW</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-06. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Manitowoc Co will report an earnings per share (EPS) of $-0.09.
The market awaits Manitowoc Co's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company missed EPS by $0.02, leading to a 11.57% increase in the share price the following trading session.
Here's a look at Manitowoc Co's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.12</td>
<td>0.06</td>
<td>0.49</td>
<td>0.18</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.10</td>
<td>-0.08</td>
<td>0.25</td>
<td>0.14</td>
</tr>
<tr>
<td>Price Change %</td>
<td>12.0%</td>
<td>-10.0%</td>
<td>-5.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746471835_0.png" alt="eps graph" />
<h3>Manitowoc Co Share Price Analysis</h3>
Shares of Manitowoc Co were trading at $8.5 as of May 02. Over the last 52-week period, shares are down 32.22%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analyst Insights on Manitowoc Co</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Manitowoc Co.
With 1 analyst ratings, Manitowoc Co has a consensus rating of Neutral. The average one-year price target is $9.0, indicating a potential 5.88% upside.
<h3>Comparing Ratings with Peers</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Wabash National, Twin Disc and Douglas Dynamics, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Wabash National, with an average 1-year price target of $14.0, suggesting a potential 64.71% upside.</li>
<li>Analysts currently favor an Buy trajectory for Twin Disc, with an average 1-year price target of $12.0, suggesting a potential 41.18% upside.</li>
<li>Analysts currently favor an Buy trajectory for Douglas Dynamics, with an average 1-year price target of $32.0, suggesting a potential 276.47% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
The peer analysis summary presents essential metrics for Wabash National, Twin Disc and Douglas Dynamics, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Manitowoc Co</td>
<td>Neutral</td>
<td>0.03%</td>
<td>$95.20M</td>
<td>9.09%</td>
</tr>
<tr>
<td>Wabash National</td>
<td>Neutral</td>
<td>-30.08%</td>
<td>$42.96M</td>
<td>-0.53%</td>
</tr>
<tr>
<td>Twin Disc</td>
<td>Buy</td>
<td>23.19%</td>
<td>$21.68M</td>
<td>0.60%</td>
</tr>
<tr>
<td>Douglas Dynamics</td>
<td>Buy</td>
<td>6.93%</td>
<td>$35.74M</td>
<td>2.94%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Manitowoc Co ranks at the top for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.
<h3>About Manitowoc Co</h3>
Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.
<h3>Understanding the Numbers: Manitowoc Co's Finances</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Manitowoc Co showcased positive performance, achieving a revenue growth rate of 0.03% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Manitowoc Co's net margin excels beyond industry benchmarks, reaching 9.51%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Manitowoc Co's ROE stands out, surpassing industry averages. With an impressive ROE of 9.09%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Manitowoc Co's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 3.3%, the company showcases efficient use of assets and strong financial health.
Debt Management: Manitowoc Co's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.68.
<a href="https://www.benzinga.com/quote/MTW/earnings">To track all earnings releases for Manitowoc Co visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Earnings Outlook For Manitowoc Co

Park-Ohio Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PKOH#NASDAQ">PKOH</a>) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Park-Ohio Hldgs to report an earnings per share (EPS) of $0.83.
Investors in Park-Ohio Hldgs are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Overview of Past Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.05, leading to a 3.6% increase in the share price on the subsequent day.
Here's a look at Park-Ohio Hldgs's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.62</td>
<td>0.89</td>
<td>0.94</td>
<td>0.79</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.67</td>
<td>1.07</td>
<td>1.02</td>
<td>0.85</td>
</tr>
<tr>
<td>Price Change %</td>
<td>4.0%</td>
<td>-4.0%</td>
<td>6.0%</td>
<td>4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746471820_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Park-Ohio Hldgs were trading at $20.61 as of May 02. Over the last 52-week period, shares are down 17.99%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/PKOH/earnings">To track all earnings releases for Park-Ohio Hldgs visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PKOH

What to Expect from Park-Ohio Hldgs's Earnings

Commercial Vehicle Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGI#NASDAQ">CVGI</a>) is preparing to release its quarterly earnings on Tuesday, 2025-05-06. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Commercial Vehicle Group to report an earnings per share (EPS) of $-0.14.
Investors in Commercial Vehicle Group are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings Track Record</h3>
Last quarter the company missed EPS by $0.08, which was followed by a 3.76% drop in the share price the next day.
Here's a look at Commercial Vehicle Group's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.07</td>
<td>0.04</td>
<td>0.17</td>
<td>0.20</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.15</td>
<td>-0.01</td>
<td>0.06</td>
<td>0.13</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>-22.0%</td>
<td>-16.0%</td>
<td>-7.000000000000001%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746471807_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Commercial Vehicle Group were trading at $0.9803 as of May 02. Over the last 52-week period, shares are down 83.73%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CVGI/earnings">To track all earnings releases for Commercial Vehicle Group visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CVGI

Preview: Commercial Vehicle Group's Earnings

comScore (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCOR#NASDAQ">SCOR</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-06. Here's a quick overview of what investors should know before the release.
Analysts are estimating that comScore will report an earnings per share (EPS) of $0.57.
The announcement from comScore is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Earnings History Snapshot</h3>
In the previous earnings release, the company missed EPS by $1.73, leading to a 21.54% increase in the share price the following trading session.
Here's a look at comScore's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.46</td>
<td>-0.33</td>
<td>0.05</td>
<td>-0.41</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.27</td>
<td>-0.16</td>
<td>-1.19</td>
<td>-1.08</td>
</tr>
<tr>
<td>Price Change %</td>
<td>22.0%</td>
<td>41.0%</td>
<td>-33.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746471794_0.png" alt="eps graph" />
<h3>comScore Share Price Analysis</h3>
Shares of comScore were trading at $5.24 as of May 02. Over the last 52-week period, shares are down 65.2%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/SCOR/earnings">To track all earnings releases for comScore visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SCOR

comScore's Earnings Outlook

Atomera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-06. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Atomera will report an earnings per share (EPS) of $-0.14.
The market awaits Atomera's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company missed EPS by $0.02, leading to a 38.5% drop in the share price the following trading session.
Here's a look at Atomera's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.14</td>
<td>0</td>
<td>-0.15</td>
<td>-0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.16</td>
<td>-0.17</td>
<td>-0.16</td>
<td>-0.19</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-38.0%</td>
<td>28.000000000000004%</td>
<td>13.0%</td>
<td>-17.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746471783_0.png" alt="eps graph" />
<h3>Market Performance of Atomera's Stock</h3>
Shares of Atomera were trading at $5.02 as of May 02. Over the last 52-week period, shares are up 15.33%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/ATOM/earnings">To track all earnings releases for Atomera visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATOM

Atomera's Earnings Outlook

WideOpenWest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOW#NYSE">WOW</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-05-06. Here's what investors need to know before the announcement.
Analysts estimate that WideOpenWest will report an earnings per share (EPS) of $-0.19. 
Investors in WideOpenWest are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
During the last quarter, the company reported an EPS missed by $0.00, leading to a 0.0% drop in the share price on the subsequent day.
Here's a look at WideOpenWest's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.13</td>
<td>-0.10</td>
<td>-0.15</td>
<td>-0.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.13</td>
<td>-0.27</td>
<td>-0.13</td>
<td>-0.18</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>4.0%</td>
<td>0.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746471769_0.png" alt="eps graph" />
<h3>Market Performance of WideOpenWest's Stock</h3>
Shares of WideOpenWest were trading at $4.49 as of May 02. Over the last 52-week period, shares are down 5.82%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/WOW/earnings">To track all earnings releases for WideOpenWest visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Peek at WideOpenWest's Future Earnings

Ranpak Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACK#NYSE">PACK</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-05-06. Here's what investors need to know before the announcement.
Analysts estimate that Ranpak Hldgs will report an earnings per share (EPS) of $-0.04. 
Ranpak Hldgs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Overview of Past Earnings</h3>
The company's EPS missed by $0.06 in the last quarter, leading to a 5.92% drop in the share price on the following day.
Here's a look at Ranpak Hldgs's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.04</td>
<td>-0.04</td>
<td>-0.06</td>
<td>-0.07</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.10</td>
<td>-0.10</td>
<td>0.07</td>
<td>-0.10</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-6.0%</td>
<td>0.0%</td>
<td>-9.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746471761_0.png" alt="eps graph" />
<h3>Market Performance of Ranpak Hldgs's Stock</h3>
Shares of Ranpak Hldgs were trading at $4.42 as of May 02. Over the last 52-week period, shares are down 38.5%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/PACK/earnings">To track all earnings releases for Ranpak Hldgs visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PACK

Ranpak Hldgs's Earnings: A Preview

Sotera Health shares are trading higher after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $14 to $17.

Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-05-06. Here's what investors need to know before the announcement.
Analysts estimate that Myriad Genetics will report an earnings per share (EPS) of $-0.06. 
Investors in Myriad Genetics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Overview of Past Earnings</h3>
Last quarter the company missed EPS by $0.00, which was followed by a 14.8% drop in the share price the next day.
Here's a look at Myriad Genetics's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.03</td>
<td>0.02</td>
<td>-0.01</td>
<td>-0.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.03</td>
<td>0.06</td>
<td>0.05</td>
<td>-0.01</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-15.0%</td>
<td>-1.0%</td>
<td>3.0%</td>
<td>21.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746471745_0.png" alt="eps graph" />
<h3>Myriad Genetics Share Price Analysis</h3>
Shares of Myriad Genetics were trading at $7.56 as of May 02. Over the last 52-week period, shares are down 61.02%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MYGN/earnings">To track all earnings releases for Myriad Genetics visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MYGN

Myriad Genetics's Earnings: A Preview

Harmony Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRMY#NASDAQ">HRMY</a>) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Harmony Biosciences to report an earnings per share (EPS) of $1.09.
The market awaits Harmony Biosciences's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings History Snapshot</h3>
In the previous earnings release, the company beat EPS by $0.26, leading to a 9.47% drop in the share price the following trading session.
Here's a look at Harmony Biosciences's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.82</td>
<td>0.66</td>
<td>-0.06</td>
<td>0.62</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.08</td>
<td>1.03</td>
<td>1.05</td>
<td>0.88</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-9.0%</td>
<td>-19.0%</td>
<td>2.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746471737_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Harmony Biosciences were trading at $30.32 as of May 02. Over the last 52-week period, shares are down 3.16%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<h3>Analyst Views on Harmony Biosciences</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Harmony Biosciences.
Harmony Biosciences has received a total of 12 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $54.5, the consensus suggests a potential 79.75% upside.
<h3>Comparing Ratings with Peers</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Supernus Pharmaceuticals and ANI Pharmaceuticals, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Supernus Pharmaceuticals, with an average 1-year price target of $36.0, suggesting a potential 18.73% upside.</li>
<li>Analysts currently favor an Buy trajectory for ANI Pharmaceuticals, with an average 1-year price target of $84.29, suggesting a potential 178.0% upside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
The peer analysis summary provides a snapshot of key metrics for Supernus Pharmaceuticals and ANI Pharmaceuticals, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Harmony Biosciences Hldgs</td>
<td>Buy</td>
<td>19.51%</td>
<td>$146.86M</td>
<td>7.88%</td>
</tr>
<tr>
<td>Supernus Pharmaceuticals</td>
<td>Neutral</td>
<td>5.99%</td>
<td>$148.06M</td>
<td>1.50%</td>
</tr>
<tr>
<td>ANI Pharmaceuticals</td>
<td>Buy</td>
<td>44.75%</td>
<td>$110.29M</td>
<td>-2.64%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Harmony Biosciences ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it has the lowest Return on Equity.
<h3>Delving into Harmony Biosciences's Background</h3>
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
<h3>Harmony Biosciences: Delving into Financials</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Harmony Biosciences displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 19.51%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Harmony Biosciences's net margin is impressive, surpassing industry averages. With a net margin of 24.58%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 7.88%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Harmony Biosciences's ROA excels beyond industry benchmarks, reaching 5.13%. This signifies efficient management of assets and strong financial health.
Debt Management: Harmony Biosciences's debt-to-equity ratio is below the industry average. With a ratio of 0.27, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/HRMY/earnings">To track all earnings releases for Harmony Biosciences visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HRMY

Harmony Biosciences's Earnings: A Preview

Financial giants have made a conspicuous bearish move on Maplebear. Our analysis of options history for Maplebear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) revealed 8 unusual trades.
Delving into the details, we found 12% of traders were bullish, while 62% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $199,200, and 3 were calls, valued at $272,000.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $45.0 to $50.0 for Maplebear over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Maplebear's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Maplebear's substantial trades, within a strike price spectrum from $45.0 to $50.0 over the preceding 30 days.
<h3>Maplebear Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746471736_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CART</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$8.3</td>
<td>$8.1</td>
<td>$8.2</td>
<td>$45.00</td>
<td>$157.4K</td>
<td>543</td>
<td align="right">300</td>
</tr>
<tr>
<td>CART</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$8.3</td>
<td>$8.1</td>
<td>$8.2</td>
<td>$45.00</td>
<td>$88.5K</td>
<td>543</td>
<td align="right">108</td>
</tr>
<tr>
<td>CART</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.6</td>
<td>$7.4</td>
<td>$7.6</td>
<td>$50.00</td>
<td>$48.6K</td>
<td>1.3K</td>
<td align="right">277</td>
</tr>
<tr>
<td>CART</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.8</td>
<td>$7.6</td>
<td>$7.8</td>
<td>$50.00</td>
<td>$43.6K</td>
<td>1.3K</td>
<td align="right">369</td>
</tr>
<tr>
<td>CART</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.7</td>
<td>$7.4</td>
<td>$7.6</td>
<td>$50.00</td>
<td>$38.0K</td>
<td>1.3K</td>
<td align="right">179</td>
</tr>
</tbody>
</table>

<h3>About Maplebear</h3>
Maplebear (Instacart) operates a leading grocery delivery platform in the United States and Canada. The company partners with various regional and national grocers, which offer their selection of food and other goods to customers through Instacart's ubiquitous platform. Once an item is ordered through Instacart's site, the item is picked and delivered to the customer's home by one of the platform's 600,000 shoppers, who are classified as independent contractors. Instacart earns fees based on average order value and leverages its platform's high usage to sell advertising, mainly to consumer-packaged goods companies. Instacart currently has around 8 million monthly active users (or orderers) on its platform.
Following our analysis of the options activities associated with Maplebear, we pivot to a closer look at the company's own performance.
<h3>Where Is Maplebear Standing Right Now?</h3>
<ul>
<li>With a trading volume of 5,993,897, the price of CART is up by 4.31%, reaching $47.17.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 92 days from now.</li>
</ul>
<h3>Expert Opinions on Maplebear</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $54.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on Maplebear, which currently sits at a price target of $54. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Maplebear, targeting a price of $44. 
&#x2A; An analyst from JMP Securities downgraded its action to Market Outperform with a price target of $55. 
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $56. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Maplebear, targeting a price of $61. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Maplebear options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Comments

Soleno Therapeutics

뉴스

파트너 / 기고자

벤징가 글로벌